Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
2019 ◽
Vol 6
(6)
◽
pp. e355-e363
◽
David A Wohl
◽
Yazdan Yazdanpanah
◽
Axel Baumgarten
◽
Amanda Clarke
◽
Melanie A Thompson
◽
...
2017 ◽
Vol 390
(10107)
◽
pp. 2073-2082
◽
Paul E Sax
◽
Anton Pozniak
◽
M Luisa Montes
◽
Ellen Koenig
◽
Edwin DeJesus
◽
...
2017 ◽
Vol 390
(10107)
◽
pp. 2063-2072
◽
Joel Gallant
◽
Adriano Lazzarin
◽
Anthony Mills
◽
Chloe Orkin
◽
Daniel Podzamczer
◽
...
2019 ◽
Vol 6
(6)
◽
pp. e364-e372
◽
Hans-Jürgen Stellbrink
◽
José R Arribas
◽
Jeffrey L Stephens
◽
Helmut Albrecht
◽
Paul E Sax
◽
...
2020 ◽
Vol 7
(6)
◽
pp. e389-e400
◽
Chloe Orkin
◽
Edwin DeJesus
◽
Paul E Sax
◽
Jose R Arribas
◽
Samir K Gupta
◽
...
2015 ◽
Vol 385
(9987)
◽
pp. 2606-2615
◽
Paul E Sax
◽
David Wohl
◽
Michael T Yin
◽
Frank Post
◽
Edwin DeJesus
◽
...
Kiat Ruxrungtham
◽
Wirach Maek-a-nantawat
Onyema Ogbuagu
◽
Peter J. Ruane
◽
Daniel Podzamczer
◽
Laura C. Salazar
◽
Keith Henry
◽
...
2017 ◽
Vol 4
(5)
◽
pp. e205-e213
◽
Edwin DeJesus
◽
Moti Ramgopal
◽
Gordon Crofoot
◽
Peter Ruane
◽
Anthony LaMarca
◽
...
Kiat Ruxrungtham
◽
Wirach Maek-a-nantawat
Close
Export Citation Format
Close
Share Document
Close